Adalimumab treatment for psoriasis - safety in numbers

被引：0
|
作者：
Fleming, P. [1 ]
机构：
[1] Lynde Inst Dermatol, 5 Washington St, Markham, ON L3P 2R3, Canada
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2019年 / 180卷 / 01期
关键词：
EFALIZUMAB; MODERATE;
D O I：
10.1111/bjd.17322
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：14 / 15
页数：2
相关论文
共 50 条
  • [21] Long-term safety and efficacy of adalimumab in the treatment of moderate to severe chronic plaque psoriasis
    Langley, R
    Leonardi, C
    Toth, D
    Chen, D
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P2 - P2
  • [22] The effectiveness and safety of adalimumab in the treatment of non-reimbursed patients with mild-to-moderate psoriasis
    Chiu, H-Y.
    Wang, T-S.
    Chang, C-Y.
    Tsai, T-F.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2012, 26 (08) : 991 - 998
  • [23] Adalimumab treatment for moderate psoriasis reduces the risk of transitioning to severe psoriasis
    Papp, Kim
    Signorovitch, James
    Mulani, Parvzez
    Gupta, Shiraz
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (03) : AB181 - AB181
  • [24] Adalimumab in children and adolescents with severe plaque psoriasis: a safety evaluation
    Zangrilli, A.
    Bavetta, M.
    Bianchi, L.
    EXPERT OPINION ON DRUG SAFETY, 2020, 19 (04) : 433 - 438
  • [25] Effectiveness and safety of Adalimumab in psoriasis and its influence on gut microbiome
    Zhao, Lihong
    Zhang, Xinyue
    Zhu, Longfei
    Geng, Songmei
    Guo, Kun
    MICROBIAL PATHOGENESIS, 2022, 162
  • [26] The Long-Term Safety of Adalimumab Treatment in Moderate to Severe Psoriasis A Comprehensive Analysis of All Adalimumab Exposure in All Clinical Trials
    Leonardi, Craig
    Papp, Kim
    Strober, Bruce
    Reich, Kristian
    Asahina, Akihiko
    Gu, Yihua
    Beason, Joseph
    Rozzo, Stephen
    Tyring, Stephen
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2011, 12 (05) : 321 - 337
  • [27] Efficacy and safety of adalimumab in psoriasis and psoriatic arthritis: ongoing results
    Papoutsaki, M
    Bianchi, L
    Chimenti, MS
    Di Stefani, A
    Diluvio, L
    Chimenti, S
    BRITISH JOURNAL OF DERMATOLOGY, 2006, 154 (01)
  • [28] Adalimumab for psoriasis
    Cather, J
    Menter, A
    Abramovits, W
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P175 - P175
  • [29] PSORIASIS Adalimumab
    Aubin, F.
    Barthelemy, H.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2011, 138 (12): : 842 - 844
  • [30] Drug Survival Associated With Effectiveness and Safety of Treatment With Guselkumab, Ixekizumab, Secukinumab, Ustekinumab, and Adalimumab in Patients With Psoriasis
    Yiu, Zenas Z. N.
    Becher, Gabrielle
    Kirby, Brian
    Laws, Philip
    Reynolds, Nick J.
    Smith, Catherine H.
    Warren, Richard B.
    Griffiths, Christopher E. M.
    JAMA DERMATOLOGY, 2022, 158 (10) : 1131 - 1141
12345